SE9904128D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE9904128D0
SE9904128D0 SE9904128A SE9904128A SE9904128D0 SE 9904128 D0 SE9904128 D0 SE 9904128D0 SE 9904128 A SE9904128 A SE 9904128A SE 9904128 A SE9904128 A SE 9904128A SE 9904128 D0 SE9904128 D0 SE 9904128D0
Authority
SE
Sweden
Prior art keywords
novel compounds
medicaments
processes
formula
preparation
Prior art date
Application number
SE9904128A
Other languages
Swedish (sv)
Inventor
David Hardern
Anthony Ingall
Paul Willis
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9904128A priority Critical patent/SE9904128D0/en
Publication of SE9904128D0 publication Critical patent/SE9904128D0/en
Priority to JP2001538927A priority patent/JP2003514827A/en
Priority to PCT/SE2000/002230 priority patent/WO2001036438A1/en
Priority to AU17475/01A priority patent/AU1747501A/en
Priority to EP00980179A priority patent/EP1232172A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12Triazine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom

Abstract

The invention provides novel ribose compounds of formula (I); their use as medicaments, compositions containing them and processes for their preparation.
SE9904128A 1999-11-15 1999-11-15 Novel compounds SE9904128D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9904128A SE9904128D0 (en) 1999-11-15 1999-11-15 Novel compounds
JP2001538927A JP2003514827A (en) 1999-11-15 2000-11-14 New ribose compounds
PCT/SE2000/002230 WO2001036438A1 (en) 1999-11-15 2000-11-14 Novel ribose compounds
AU17475/01A AU1747501A (en) 1999-11-15 2000-11-14 Novel ribose compounds
EP00980179A EP1232172A1 (en) 1999-11-15 2000-11-14 Novel ribose compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904128A SE9904128D0 (en) 1999-11-15 1999-11-15 Novel compounds

Publications (1)

Publication Number Publication Date
SE9904128D0 true SE9904128D0 (en) 1999-11-15

Family

ID=20417725

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904128A SE9904128D0 (en) 1999-11-15 1999-11-15 Novel compounds

Country Status (5)

Country Link
EP (1) EP1232172A1 (en)
JP (1) JP2003514827A (en)
AU (1) AU1747501A (en)
SE (1) SE9904128D0 (en)
WO (1) WO2001036438A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7749981B2 (en) 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
ATE469157T1 (en) 2003-10-21 2010-06-15 Inspire Pharmaceuticals Inc TETRAHYDROFUROÄ3,4-DIOXOL COMPOUNDS AND COMPOSITIONS AND METHODS FOR INHIBITING TROMBOCYTE AGGREGATION
US7335648B2 (en) 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
US7504497B2 (en) 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
WO2005039590A1 (en) 2003-10-21 2005-05-06 Inspire Pharmaceuticals, Inc. Non-nucleotide compositions and method for treating pain
JP2005287503A (en) * 2004-04-01 2005-10-20 Aventis Pharma Deutschland Gmbh Method for identifying risk for thrombogenic disorder by determining tafi-ile347 polymorphism
US7932376B2 (en) 2005-05-05 2011-04-26 Inspire Pharmaceuticals, Inc. Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
JPWO2007020935A1 (en) * 2005-08-17 2009-02-26 小野薬品工業株式会社 Pain therapeutic agent comprising P2Y12 receptor and / or P2Y14 receptor blocker
WO2014206187A1 (en) 2013-06-24 2014-12-31 苏州明锐医药科技有限公司 Preparation method of ticagrelor and intermediates thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100444123B1 (en) * 1995-07-11 2004-10-14 아스트라제네카 악티에볼라그 New Inhibitors of Platelet Aggregation
EP0946561B1 (en) * 1996-12-20 2002-02-13 AstraZeneca AB Triazolo(4,5-d)pyrimidinyl derivatives and their use as medicaments
SE9702772D0 (en) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
AR017014A1 (en) * 1997-07-22 2001-08-22 Astrazeneca Ab TRIAZOL COMPOUNDS [4,5-D] PYRIMIDINE, PHARMACEUTICAL COMPOSITIONS, USE OF THE SAME TO PREPARE MEDICATIONS AND PROCESSES FOR THE PREPARATION OF SUCH COMPOUNDS

Also Published As

Publication number Publication date
EP1232172A1 (en) 2002-08-21
AU1747501A (en) 2001-05-30
WO2001036438A1 (en) 2001-05-25
JP2003514827A (en) 2003-04-22

Similar Documents

Publication Publication Date Title
IS6658A (en) New compounds
ATE296826T1 (en) PYRAZOLO(1,5)PYRIDINE DERIVATIVES
DE60112609D1 (en) Pyrazolopyridine
ATE433447T1 (en) PYRIMIIDINE COMPOUNDS
HK1048990A1 (en) Novel compounds.
SE9904652D0 (en) Novel Compounds
ATE332301T1 (en) ANTIVIRAL PYRAZOLOPYRIDINE COMPOUNDS
AU2003228770A8 (en) Substituted pyrazolopyrimidines
ES2243579T3 (en) DERIVATIVES OF PIRAZOLOPIRIDENO.
MXPA03004549A (en) 3-arylindole derivatives and their use as cb2 receptor agonists.
SE0104251D0 (en) Novel compounds
SE0302139D0 (en) Novel compounds
NO20043016L (en) 6-aminomorphinan derivatives, process for preparation and use thereof
TW200604197A (en) New compounds
SE9804212D0 (en) Compounds
SE0101038D0 (en) Novel compounds
DE60301339D1 (en) PYRAZOLOPYRIMIDINE AND PYRAZOLOTRIAZINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEREOF
SE0303280D0 (en) Novel compounds
SE9904128D0 (en) Novel compounds
MXPA02012426A (en) Novel compounds.
DE60201074D1 (en) Pyrazolopyridinderivate
SE9802574D0 (en) Novel compounds
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
SE0302755D0 (en) Novel compounds
SE0004480D0 (en) Novel compounds